Investor Insight With a focused and cost-efficient exploration strategy, North Shore Uranium is building a dual-jurisdiction uranium portfolio in two of North America’s most...
Lithium prices and mining stocks around the world soared this week after Chinese battery giant Contemporary Amperex Technology (CATL) (SZSE:300750,HKEX:3750) suspended operations at one...
Sranan Gold Corp. (CSE: SRAN) (FSE: P84) (Tradegate: P84) (‘Sranan’ or the ‘Company’) announces the commencement of its diamond drilling program for the Tapanahony...
Undrilled silver-rich and polymetallic occurrences are dispersed across a 55 km highly prospective east-west corridor Silver47 Exploration Corp. (TSXV: AGA,OTC:AAGAF) (OTCQB: AAGAF) (‘Silver47’ or...
Description The suspension of trading in the securities of Jindalee Lithium Limited (‘JLL’) will be lifted immediately following the release by JLL of an...
Jindalee Lithium Limited (Jindalee, the Company; ASX: JLL, OCTQX: JNDAF) is pleased to advise that its recently completed Pre-Feasibility Study (PFS), on the Company’s...
The Russian government has imposed temporary restrictions on enriched uranium exports to the US. Announced on November 15, the move follows the US’ decision...
Ionic Rare Earths Limited (“IonicRE” or the “Company”) (ASX: IXR) wholly owned subsidiary Ionic Technologies is on track for the development of a unique...
Perth, Australia (ABN Newswire) – BPH Energy Limited (ASX:BPH) provide a presentation by investee Cortical Dynamics at the Health Innovation Frontier Forum on 18th...
Provaris Energy Ltd (ASX.PV1, Provaris, the Company) is pleased to present the notice of initial substantial holder. Click here for the full ASX Release...
Lightning Minerals (L1M or the Company) is delighted to announce the discovery of spodumene within a lithium bearing pegmatite at the Company’s recently acquired...
Australian antiviral drug development company, Island Pharmaceuticals Ltd (ASX: ILA; Island or the Company) is pleased to announce progress on its ISLA-101 Phase 2a/b...
Description During a fireside chat with analysts from Brookline Capital Markets, Radiopharm Theranostics’ (ASX:RAD) CEO Riccardo Canevari provided clinical and corporate updates highlighting the...
Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet medical need,...